1.8050.00% ( 0.000 )
Suspended: Oct 6, 09:20:00 (EDT)Current ValuationThe current P/E ratio is -1.10, within the reasonable range, cheaper than 99.23% of the time in the past 3 years, and the industry ranks 58/93, the industry Median -0.53.
-1.1xP/E
--Stock price
-1.1xP/E
Stock price--
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -1.07x
- Typical range
- -1.10x–-0.31x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
015304560
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
NJDCYUSNidec | -4.19x | -- | $15.60B |
ATKRUSAtkore | -19.68x | 275.56% | $3.20B |
PLUGUSPlug Power | -1.61x | 72.21% | $2.64B |
FCELUSFuelCell Energy | -8.10x | 61.69% | $1.44B |
FLNCUSFluence Energy | -17.46x | 198.41% | $1.41B |
AMPXUSAmprius Tech | -35.95x | 79.05% | $1.38B |
EOSEUSEOS Energy Enterprises | -1.16x | 127.79% | $1.19B |
ADSEUSAds-Tec Energy | -7.90x | -- | $756.37M |
HYLNUSHyliion | -14.17x | 7.58% | $739.39M |
BLDPUSBallard Power | -8.04x | 38.63% | $621.10M |
ARRYUSArray Tech | -4.06x | 139.27% | $600.63M |
ENVXUSEnovix | -3.45x | 7.13% | $585.93M |
FACUSFactorial Energy | -8.32x | 95.37% | $585.42M |
SESUSSES AI | -4.57x | 18.77% | $310.32M |
CHPTUSChargePoint | -1.36x | 44.59% | $239.77M |
EAFUSGraftech | -1.30x | 31.91% | $230.13M |
NEOVUSNeoVolta | -8.12x | 30.45% | $174.24M |
SKYXUSSKYX Platforms | -4.57x | 27.68% | $155.75M |
KULRUSKULR Tech | -1.15x | 8.97% | $117.91M |
CBATUSCBAK Energy Tech | -6.80x | 20.00% | $116.13M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
